| Procedure . | Protocol 1 . | Protocol 2 . | Protocol 3 . |
|---|---|---|---|
| Buffer delivery | Constant flow by minipump | Gravity-induced flow | Constant pressure monitored and adjusted by minipump |
| Cannulation | Excision, then cannulation | In-chest cannulation | In-chest cannulation |
| Buffer contents | NaCl, KCl, NaH2PO4, NaHCO3, MgSO4, glucose, BDM, taurine | NaCl, KCl, MgCl2, HEPES, glucose, taurine, Na2HPO4 | NaCl, KCl, MgSO4, Na2HPO4, KH2PO4, NaHCO3, KHCO3, HEPES, glucose |
| Isolation initial survivorship rate | 49–54% rod shaped | 73–83% rod shaped | 80–90% rod shaped |
| Basal CFP/YFP ratio (a.u.) | 0.9925–1.0051 | 0.9957–1.0012 | 0.9802–0.9972 |
| Normalized 40 h AKAR3 FRET Ratio change (a.u.) | 1.245–1.2514 | 1.236–1.2416 | 1.267–1.2692 |
| Procedure . | Protocol 1 . | Protocol 2 . | Protocol 3 . |
|---|---|---|---|
| Buffer delivery | Constant flow by minipump | Gravity-induced flow | Constant pressure monitored and adjusted by minipump |
| Cannulation | Excision, then cannulation | In-chest cannulation | In-chest cannulation |
| Buffer contents | NaCl, KCl, NaH2PO4, NaHCO3, MgSO4, glucose, BDM, taurine | NaCl, KCl, MgCl2, HEPES, glucose, taurine, Na2HPO4 | NaCl, KCl, MgSO4, Na2HPO4, KH2PO4, NaHCO3, KHCO3, HEPES, glucose |
| Isolation initial survivorship rate | 49–54% rod shaped | 73–83% rod shaped | 80–90% rod shaped |
| Basal CFP/YFP ratio (a.u.) | 0.9925–1.0051 | 0.9957–1.0012 | 0.9802–0.9972 |
| Normalized 40 h AKAR3 FRET Ratio change (a.u.) | 1.245–1.2514 | 1.236–1.2416 | 1.267–1.2692 |